Skip to main content
Sugentech, Inc. logo

Sugentech, Inc. — Investor Relations & Filings

Ticker · 253840 ISIN · KR7253840003 KO Manufacturing
Filings indexed 296 across all filing types
Latest filing 2021-10-18 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 253840

About Sugentech, Inc.

https://www.sugentech.com/en/

Sugentech, Inc. is an in-vitro diagnostics (IVD) company that develops and commercializes diagnostic solutions by integrating biotechnology, nanotechnology, and information technology. The company's product portfolio serves diverse healthcare settings, from large hospitals and laboratories to smaller clinics and home users. Key offerings include automated multi-immunoblot systems, point-of-care testing (POCT) platforms, and self-diagnostic kits for personal use, such as ovulation and pregnancy tests. Sugentech leverages proprietary technologies in developing high-level antibodies and advanced nanoparticles to create highly sensitive and precise immunochemical assays, underpinning its digital healthcare diagnostic platform for personalized medicine.

Recent filings

Filing Released Lang Actions
전환가액의조정(제2회차)
Share Issue/Capital Change Classification · 100% confidence The document is an official regulatory filing regarding the adjustment of the conversion price for convertible bonds (제2회차 전환가액의 조정). This type of disclosure relates to changes in the company's capital structure and financing terms. According to the provided definitions, 'Capital/Financing Update' (CAP) is the most appropriate category for updates on financing activities and capital structure changes.
2021-10-18 Korean
기타경영사항(자율공시)(전환우선주 전환가액 조정)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the Korean stock exchange (KRX) regarding a 'Conversion Price Adjustment' for convertible preferred shares. This type of corporate action, which involves changes to the capital structure and potential dilution, falls under the category of 'Share Issue/Capital Change' (SHA) as it directly relates to the terms of issued securities and their conversion rights.
2021-10-18 Korean
단일판매ㆍ공급계약체결
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory announcement regarding a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결) by the company Sugentech. It details the contract value, the counterparty, the product (COVID-19 antigen test kits), and the contract period. Since this is a specific regulatory disclosure of a business contract that does not fit into the other specialized categories like M&A or financial reports, it is classified as a Regulatory Filing (RNS).
2021-09-14 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a formal announcement of a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) by Sugentech. It details the contract value, the counterparty, the product (COVID-19 antigen rapid test kits), and the contract period. This type of disclosure regarding specific business contracts does not fit into the specific categories like 10-K, ER, or M&A, and is best classified as a general regulatory filing (RNS) under the provided schema.
2021-09-02 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from a Korean company (Sugentech) announcing a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). It details the contract value, the counterparty, the product (COVID-19 diagnostic kits), and the contract duration. Since this is a specific announcement of a commercial contract and does not fit into the other specialized categories like M&A or financial reports, it is classified as a general regulatory filing.
2021-08-18 Korean
[기재정정]사업보고서 (2020.12)
Annual Report Classification · 100% confidence The document is a '사업보고서' (Business Report), which is the Korean equivalent of an Annual Report (10-K). It covers the fiscal year from 2020.01.01 to 2020.12.31, includes detailed company information, history, capital changes, and management details. It is a comprehensive report rather than an announcement or a summary, fitting the definition of an Annual Report. FY 2020
2021-08-13 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.